Table 1.
Expression systems available for the production of membrane proteins for NMR spectroscopy
Host organisms | Advantages | Disadvantages | ||
---|---|---|---|---|
Prokaryotes
| ||||
Esherichia coli (Gram −) | Rapid. Easy. Scaleable. Cheap. inducible. |
Excellent isotope labeling schemes, including for perdeuteration. Various vectors and strains. |
Lacking post- translational modifications of higher organisms. Different codon usage. |
Prone to inclusion body formation Nonfunctional expression. |
|
|
|
||
Lactoccccus lactis (Gram +) | Increased functional expression. Single membrane. |
Isotopic labeling schemes need to be explored. Limited numbers of vectors and strains. |
||
| ||||
Eukaryotes | ||||
| ||||
Yeast | Functional expression. | Limited post-translational modification available. | ||
Pichia pastoris | Limited post-translational modification. | Potential proteolysis of target proteins. | ||
Cheap, scalable, inducible. | ||||
Uniform isotopic enrichment methods, including perdeuteration, are available. |
||||
| ||||
Insect cells | Moderately low yields. | |||
Sf9 | Compatible post-translational modifications, targeting, insertion and folding. |
Post-translational modifications differ from higher organisms. Limited isotope labeling schemes. |
||
S21 | High functional expression. | Relatively expensive. | ||
| ||||
Mammalian cells | Compatible post-translational modifications, targeting, insertion and folding. |
Low expression yields. | ||
HEK293 | Very limited isotope labeling schemes. | |||
CHO | High functional expression. | Relatively expensive. | ||
| ||||
Rapid, easy to control. | ||||
No toxicity. | Expensive. | |||
Cell-free | Versatile labeling incorporation. Scalable. |
Limited post-translational modifications unless mammalian microsomes used. |